742 related articles for article (PubMed ID: 22241220)
21. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
22. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P
Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214
[TBL] [Abstract][Full Text] [Related]
23. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
24. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
25. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
Okano J; Nagahara T; Matsumoto K; Murawaki Y
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):543-51. PubMed ID: 18346049
[TBL] [Abstract][Full Text] [Related]
26. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Liu ZM; Tseng JT; Hong DY; Huang HS
Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
[TBL] [Abstract][Full Text] [Related]
27. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
[TBL] [Abstract][Full Text] [Related]
28. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
29. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
30. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
Matsushima-Nishiwaki R; Adachi S; Yoshioka T; Yasuda E; Yamagishi Y; Matsuura J; Muko M; Iwamura R; Noda T; Toyoda H; Kaneoka Y; Okano Y; Kumada T; Kozawa O
J Cell Biochem; 2011 Nov; 112(11):3430-9. PubMed ID: 21769911
[TBL] [Abstract][Full Text] [Related]
31. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
Huynh H; Nguyen TT; Chow KH; Tan PH; Soo KC; Tran E
BMC Gastroenterol; 2003 Aug; 3():19. PubMed ID: 12906713
[TBL] [Abstract][Full Text] [Related]
33. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
34. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW
Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040
[TBL] [Abstract][Full Text] [Related]
35. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
36. Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism.
Ma XN; Liu XY; Yang YF; Xiao FJ; Li QF; Yan J; Zhang QW; Wang LS; Li XY; Wang H
Biochem Biophys Res Commun; 2011 Jul; 410(4):803-8. PubMed ID: 21703232
[TBL] [Abstract][Full Text] [Related]
37. Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251.
Liu B; Tian D; Yi W; Wu L; Cai Q; Dong H; Shen H; Ji B; Wang L; Zhang S; Ruan D; Chen Q
Cell Biochem Biophys; 2010 Nov; 58(2):91-6. PubMed ID: 20730570
[TBL] [Abstract][Full Text] [Related]
38. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.
Amann T; Bataille F; Spruss T; Mühlbauer M; Gäbele E; Schölmerich J; Kiefer P; Bosserhoff AK; Hellerbrand C
Cancer Sci; 2009 Apr; 100(4):646-53. PubMed ID: 19175606
[TBL] [Abstract][Full Text] [Related]
39. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
40. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
